Adaptive AAC for Communication Disorders

Overseen By Joshua Kline, Ph.D.

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: Altec Inc.

Disqualifiers: Non-English speaker, Musculoskeletal conditions, Cardiac or respiratory, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 1 year

20 Participants Needed

Trial Summary

What is the purpose of this trial?

The overall objective of this study is to develop an Augmentative and Alternative Communication (AAC) system that is effective in delivering a person-centric communication device that will provide a versatile access method that can automatically learn and adapt to the user's physical abilities by creating a personalized, comprehensive keyboard interface for communication, not otherwise available to people in need of alternative communication.

Research Team

Gianluca De Luca, M.S.

Principal Investigator

Altec Inc.

Eligibility Criteria

This trial is for individuals aged 6 or older with developmental communication disorders who can spell, follow instructions, and read large text. They must be able to attend multiple testing sessions and have voluntary muscle control in the head, hand, or foot without medical restrictions on movement.

Inclusion Criteria

I am 6 years old or older.

I can spell, follow instructions, and read large text.

I can control my head, hand, or foot well enough to use a special communication device.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive both Experimental and Generic AAC systems to communicate, focusing on usability, improved performance, acceptance, and perceived benefit

1 year

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Experimental AAC
• Generic AAC

Trial Overview The study aims to develop a personalized Augmentative and Alternative Communication (AAC) system that adapts to the user's abilities. It will create a custom keyboard interface for those needing alternative methods of communication due to severe motor impairments.

Participant Groups

Group I: Experimental and Generic Communication Interfaces for AAC Experimental Treatment 2 Interventions

Each participant receives both Experimental and Generic AAC systems to communicate - in that order.

Who Is Running the Clinical Trial?

Altec Inc.

Lead Sponsor

Trials

5

Recruited

110+

University of Nebraska

Collaborator

Trials

563

Recruited

1,147,000+